LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 69.06 | 17.25 | 1 | 5242 | 0.0002 | -0.2920 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 69.06 | 17.25 | 515 | 5242 | 0.0982 | 0.5095 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.03 | 17.25 | 1 | 5367 | 0.0002 | -0.2910 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.03 | 17.25 | 833 | 5367 | 0.1552 | 0.5971 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.03 | 17.25 | 1 | 5367 | 0.0002 | -0.2910 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.03 | 17.25 | 432 | 5367 | 0.0805 | 0.4754 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 73.00 | 17.25 | 1 | 5546 | 0.0002 | -0.2896 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 73.00 | 17.25 | 888 | 5546 | 0.1601 | 0.6051 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 73.00 | 17.25 | 1 | 5546 | 0.0002 | -0.2896 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 73.00 | 17.25 | 430 | 5546 | 0.0775 | 0.4713 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 74.97 | 17.25 | 1 | 5618 | 0.0002 | -0.2891 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 74.97 | 17.25 | 894 | 5618 | 0.1591 | 0.6047 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 74.97 | 17.25 | 1 | 5618 | 0.0002 | -0.2891 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 74.97 | 17.25 | 385 | 5618 | 0.0685 | 0.4507 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 76.94 | 17.25 | 1 | 5681 | 0.0002 | -0.2886 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 76.94 | 17.25 | 922 | 5681 | 0.1623 | 0.6092 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 76.94 | 17.25 | 1 | 5681 | 0.0002 | -0.2886 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 76.94 | 17.25 | 319 | 5681 | 0.0561 | 0.4174 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 78.91 | 17.25 | 1 | 5730 | 0.0002 | -0.2882 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 78.91 | 17.25 | 938 | 5730 | 0.1637 | 0.6114 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 78.91 | 17.25 | 1 | 5730 | 0.0002 | -0.2882 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 78.91 | 17.25 | 314 | 5730 | 0.0548 | 0.4140 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 80.88 | 17.25 | 1 | 5826 | 0.0002 | -0.2876 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 80.88 | 17.25 | 929 | 5826 | 0.1595 | 0.6073 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 80.88 | 17.25 | 1 | 5826 | 0.0002 | -0.2876 | MN20160310_N02 | K04 |